• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. PROFEMUR STEM; HIP COMPONENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT ORTHOPEDICS INC. PROFEMUR STEM; HIP COMPONENT Back to Search Results
Device Problem Material Fragmentation (1261)
Patient Problem Pain (1994)
Event Type  Injury  
Manufacturer Narrative
This event will be updated once the investigation is complete.Trends will be evaluated.
 
Event Description
Allegedly, patient was revised due to pain and metallosis.Additional information: right hip.
 
Manufacturer Narrative
Additional information received on 01/14/2021 please void the following initial and final report mfr report# 3010536692-2020-00110.Since the additional information has determined that this component did not contribute to the incident originally reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROFEMUR STEM
Type of Device
HIP COMPONENT
Manufacturer (Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
MDR Report Key9695986
MDR Text Key178647176
Report Number3010536692-2020-00110
Device Sequence Number1
Product Code JDI
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Type of Report Initial,Followup,Followup
Report Date 01/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date01/22/2020
Initial Date Manufacturer Received 01/22/2020
Initial Date FDA Received02/11/2020
Supplement Dates Manufacturer Received01/22/2020
01/22/2020
Supplement Dates FDA Received09/16/2020
01/15/2021
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-